449 related articles for article (PubMed ID: 16428474)
1. Stress hormone-mediated invasion of ovarian cancer cells.
Sood AK; Bhatty R; Kamat AA; Landen CN; Han L; Thaker PH; Li Y; Gershenson DM; Lutgendorf S; Cole SW
Clin Cancer Res; 2006 Jan; 12(2):369-75. PubMed ID: 16428474
[TBL] [Abstract][Full Text] [Related]
2. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.
Lutgendorf SK; Cole S; Costanzo E; Bradley S; Coffin J; Jabbari S; Rainwater K; Ritchie JM; Yang M; Sood AK
Clin Cancer Res; 2003 Oct; 9(12):4514-21. PubMed ID: 14555525
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.
Landen CN; Lin YG; Armaiz Pena GN; Das PD; Arevalo JM; Kamat AA; Han LY; Jennings NB; Spannuth WA; Thaker PH; Lutgendorf SK; Savary CA; Sanguino AM; Lopez-Berestein G; Cole SW; Sood AK
Cancer Res; 2007 Nov; 67(21):10389-96. PubMed ID: 17974982
[TBL] [Abstract][Full Text] [Related]
4. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.
Yang EV; Sood AK; Chen M; Li Y; Eubank TD; Marsh CB; Jewell S; Flavahan NA; Morrison C; Yeh PE; Lemeshow S; Glaser R
Cancer Res; 2006 Nov; 66(21):10357-64. PubMed ID: 17079456
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
6. Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol.
Guo K; Ma Q; Wang L; Hu H; Li J; Zhang D; Zhang M
Oncol Rep; 2009 Oct; 22(4):825-30. PubMed ID: 19724861
[TBL] [Abstract][Full Text] [Related]
7. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
Zou M; Zhang X; Xu C
Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
[TBL] [Abstract][Full Text] [Related]
8. Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.
Lutgendorf SK; Lamkin DM; Jennings NB; Arevalo JM; Penedo F; DeGeest K; Langley RR; Lucci JA; Cole SW; Lubaroff DM; Sood AK
Clin Cancer Res; 2008 Nov; 14(21):6839-46. PubMed ID: 18980978
[TBL] [Abstract][Full Text] [Related]
9. Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells.
Bernabé DG; Tamae AC; Biasoli ÉR; Oliveira SH
Brain Behav Immun; 2011 Mar; 25(3):574-83. PubMed ID: 21187140
[TBL] [Abstract][Full Text] [Related]
10. TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103.
Lin SW; Lee MT; Ke FC; Lee PP; Huang CJ; Ip MM; Chen L; Hwang JJ
Clin Exp Metastasis; 2000; 18(6):493-9. PubMed ID: 11592306
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3].
Yuan YX; Xu WF; Liu J; Chen MH; Meng H; Qu XJ
Ai Zheng; 2006 Jun; 25(6):663-70. PubMed ID: 16764758
[TBL] [Abstract][Full Text] [Related]
12. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
Yan Y; Jiang X; Zhao Y; Wen H; Liu G
Cell Biochem Funct; 2015 Dec; 33(8):552-9. PubMed ID: 26526233
[TBL] [Abstract][Full Text] [Related]
13. Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.
Sood AK; Fletcher MS; Coffin JE; Yang M; Seftor EA; Gruman LM; Gershenson DM; Hendrix MJ
Am J Obstet Gynecol; 2004 Apr; 190(4):899-909. PubMed ID: 15118611
[TBL] [Abstract][Full Text] [Related]
14. hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness.
Choi MJ; Cho KH; Lee S; Bae YJ; Jeong KJ; Rha SY; Choi EJ; Park JH; Kim JM; Lee JS; Mills GB; Lee HY
Oncogene; 2015 Jun; 34(26):3402-12. PubMed ID: 25151968
[TBL] [Abstract][Full Text] [Related]
15. Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2.
Yuecheng Y; Xiaoyan X
Eur J Cancer Prev; 2007 Oct; 16(5):430-5. PubMed ID: 17923814
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
Hu X; Li D; Zhang W; Zhou J; Tang B; Li L
Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979
[TBL] [Abstract][Full Text] [Related]
17. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
Ellerbroek SM; Hudson LG; Stack MS
Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
Meng F; Sun G; Zhong M; Yu Y; Brewer MA
Int J Oncol; 2013 Aug; 43(2):495-502. PubMed ID: 23709006
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasion.
Belotti D; Calcagno C; Garofalo A; Caronia D; Riccardi E; Giavazzi R; Taraboletti G
Mol Cancer Res; 2008 Apr; 6(4):525-34. PubMed ID: 18403633
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.
So J; Navari J; Wang FQ; Fishman DA
Gynecol Oncol; 2004 Nov; 95(2):314-22. PubMed ID: 15491751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
